Bright Light: An Adjunct Treatment for Combat Posttraumatic Stress Disorder (PTSD)

NCT ID: NCT00701064

Last Updated: 2019-09-24

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

71 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-01-01

Study Completion Date

2019-09-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators are testing novel treatments for combat PTSD: bright light exposure and negation ion exposure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Seventy Operation Iraqi Freedom (OIF)/Operation Enduring Freedom (OEF) Veterans with posttraumatic stress disorders (PTSD) will be randomly assigned to one of two 4-week treatments (45 min/day): (1) bright light exposure or (2) a negative ion generator. Clinical assessments ,as well as self-reported measures of PTSD, anxiety, depression, and sleep will be assessed

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Posttraumatic Stress Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bright Light Exposure

Bright Light (30 min/day)

Group Type EXPERIMENTAL

Bright Light Exposure

Intervention Type OTHER

Administered via bright light box

Negative Ion Generator

Negative Ion Generator (30 min/day)

Group Type PLACEBO_COMPARATOR

Negative Ion Generator

Intervention Type OTHER

Administered via Negative Ion Generatore

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bright Light Exposure

Administered via bright light box

Intervention Type OTHER

Negative Ion Generator

Administered via Negative Ion Generatore

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Veteran of Operation Iraqi Freedom or Operation Enduring Freedom with Posttraumatic Stress Disorder
* receiving other treatment or stopped other treatment prior to study

Exclusion Criteria

* bipolar disorder
* psychosis
* alcohol/drug abuse
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Arizona State University

OTHER

Sponsor Role collaborator

VA Office of Research and Development

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Shawn D. Youngstedt, PhD

Role: PRINCIPAL_INVESTIGATOR

Wm. Jennings Bryan Dorn VA Medical Center, Columbia, SC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Wm. Jennings Bryan Dorn VA Medical Center, Columbia, SC

Columbia, Arizona, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MHBA-008-08S

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

3MDR to Treat PTSD With mTBI (3MDR)
NCT03796936 COMPLETED PHASE2
Acupuncture for PTSD
NCT02869646 COMPLETED NA
Theta-Burst Neuromodulation for PTSD
NCT02769312 COMPLETED PHASE1/PHASE2
Cognitive Training for PTSD
NCT03316196 COMPLETED NA